Ingevity (NGVT) and The Competition Head to Head Survey

Ingevity (NYSE:NGVT – Get Free Report) is one of 296 publicly-traded companies in the “Chemicals” industry, but how does it contrast to its competitors? We will compare Ingevity to similar businesses based on the strength of its risk, profitability, analyst recommendations, institutional ownership, valuation, dividends and earnings.

Volatility and Risk

Ingevity has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500. Comparatively, Ingevity’s competitors have a beta of 0.94, meaning that their average stock price is 6% less volatile than the S&P 500.

Profitability

This table compares Ingevity and its competitors’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Ingevity 5.28% 405.38% 11.41%
Ingevity Competitors -54.13% -0.44% -1.36%

Institutional and Insider Ownership

91.6% of Ingevity shares are owned by institutional investors. Comparatively, 48.0% of shares of all “Chemicals” companies are owned by institutional investors. 0.9% of Ingevity shares are owned by company insiders. Comparatively, 13.9% of shares of all “Chemicals” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and price targets for Ingevity and its competitors, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Ingevity 0 3 2 0 2.40
Ingevity Competitors 3275 12246 14161 521 2.39

Ingevity presently has a consensus price target of $80.00, suggesting a potential upside of 33.30%. As a group, “Chemicals” companies have a potential upside of 8.97%. Given Ingevity’s stronger consensus rating and higher probable upside, research analysts clearly believe Ingevity is more favorable than its competitors.

Valuation and Earnings

This table compares Ingevity and its competitors revenue, earnings per share and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Ingevity $1.17 billion -$167.10 million 35.30
Ingevity Competitors $7.97 billion $229.42 million 7.26

Ingevity’s competitors have higher revenue and earnings than Ingevity. Ingevity is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Summary

Ingevity beats its competitors on 8 of the 13 factors compared.

Ingevity Company Profile

(Get Free Report)

Ingevity is a specialty chemicals and materials company headquartered in North Charleston, South Carolina. It develops and manufactures high-performance activated carbon and specialty chemical products for industrial and consumer applications. Its activated carbon products are used in vehicle fuel-vapor emission control and other applications. The company also makes specialty chemicals and polymer materials used in areas such as pavement technologies, coatings, adhesives and elastomers. Ingevity serves customers in markets around the world.

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.